One Pager | March 31, 2024 |
Instruments | Indicative Allocation (%of net assets) | Risk Profile | |
Minimum | Maximum | Low/ Moderate/ High | |
Money Market & Debt instruments* | 0% | 100% | Low to Moderate |
Units issued by REITs & InvITs | 0% | 10% | Moderately High |
* Includes securitized debt up to 30% of the net assets of the Scheme For complete details on asset allocation for the scheme please refer SID available on www.mahindramanulife.com or visit the nearest Investor Service Centre
Benchmark: CRISIL Low Duration Debt A-I IndexNote: The data/statistics given above are to explain general market trends in the securities market, it should not be construed as any research report/ research recommendation.
CURRENT MONTH March 31, 2024 |
|
AUM (Rs. In Crore) | 499.21 |
Quarterly AAUM (Rs. In Crore) | 503.81 |
Monthly AAUM (Rs. In Crore) | 494.95 |
Annualised Portfolio YTM*1 | 8.02% |
Macaulay Duration (days) | 333.01 |
Modified Duration | 0.87 |
Residual Maturity (days) | 489.30 |
PREVIOUS MONTH February 29, 2024 |
|
AUM (Rs. In Crore) | 520.74 |
Quarterly AAUM (Rs. In Crore) | - |
Monthly AAUM (Rs. In Crore) | 511.68 |
Annualised Portfolio YTM*1 | 8.07% |
Macaulay Duration (days) | 347.42 |
Modified Duration | 0.90 |
Residual Maturity (days) | 509.19 |
**Cash & Cash Equivalents includes Fixed Deposits, Cash & Current Assets and TREPS.
Data as on March 31, 2024
**Cash & Cash Equivalents includes Fixed Deposits, Cash & Current Assets and TREPS.
Data as on March 31, 2024
CURRENT MONTH March 31, 2024 | |
Security | % to N.A. |
Axis Bank Limited (CRISIL A1+ rated CD) | 8.17% |
TATA Realty & Infrastructure Limited (ICRA AA+ rated CB) | 6.78% |
Embassy Office Parks REIT (CRISIL AAA rated CB) | 5.48% |
LIC Housing Finance Limited (CRISIL AAA rated CB) | 5.15% |
Shriram Finance Limited (CRISIL AA+ rated CB) | 5.01% |
Small Industries Dev Bank of India (CRISIL AAA rated CB) | 4.99% |
Bharti Telecom Limited (CRISIL AA+ rated CB) | 4.99% |
Export Import Bank of India (CRISIL AAA rated CB) | 4.89% |
360 One Prime Limited (CRISIL AA rated CB) | 4.82% |
ICICI Bank Limited (ICRA A1+ rated CD) | 4.76% |
Total | 55.06% |
PREVIOUS MONTH February 29, 2024 | |
Security | % to N.A. |
Axis Bank Limited (CRISIL A1+ rated CD) | 8.05% |
TATA Realty & Infrastructure Limited (ICRA AA+ rated CB) | 6.76% |
Embassy Office Parks REIT CRISIL AAA rated CB) | 5.96% |
LIC Housing Finance Limited CRISIL AAA rated CB) | 5.14% |
Shriram Finance Limited (CRISIL AA+ rated CB) | 5.02% |
Bharti Telecom Limited (CRISIL AA+ rated CB) | 5.00% |
Small Industries Dev Bank of India (CRISIL AAA rated CB) | 4.99% |
Export Import Bank of India CRISIL AAA rated CB) | 4.87% |
360 One Prime Limited (CRISIL AA rated CB) | 4.79% |
HDFC Bank Limited (CRISIL A1+ rated CD) | 4.69% |
Total | 55.28% |
FRESH ADDITIONS | COMPLETE EXITS |
Security | Security |
Motilal Oswal Financial Services Limited (CP) | Piramal Enterprises Limited (CP) |
- | Power Finance Corporation Limited (CB) |
SYSTEMATIC INVESTMENT PLAN |
WITH THIS YOU CAN • Build corpus in the long term • Take advantage of rupee cost averaging • Experience the power of compounding even on small investments |
CHOICE OF FREQUENCIES • Weekly • Monthly • Quarterly |
CHOICE OF DATES Any date of your choice |
MINIMUM AMOUNTS / INSTALMENTS • 6 instalments of ₹ 500 each under weekly frequency • 6 instalments of ₹ 500 each under monthly frequency • 4 instalments of ₹ 1500 each under quarterly frequency |
SYSTEMATIC TRANSFER PLAN |
WITH THIS YOU CAN • Take measured exposure into a new asset class • Rebalance your portfolio |
CHOICE OF FREQUENCIES • Daily • Weekly • Monthly • Quarterly |
CHOICE OF DATES Any date^ of your choice |
MINIMUM AMOUNTS / INSTALMENTS • 6 instalments of ₹500 each under daily, weekly and monthly frequency • 4 instalments of ₹1500 each under quarterly frequency |
SYSTEMATIC WITHDRAWAL PLAN |
WITH THIS YOU CAN • Meet regular expenses |
CHOICE OF DATES Any date of your choice |
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 15-Feb-17.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated
on face value of Rs. 1,000 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the
scheme has different expense structure. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period. $With effect from March 11, 2024, the First Tier benchmark
of Mahindra Manulife Low Duration Fund has been changed.
^Benchmark CAGR – Compounded Annual Growth Rate. ##Dedicated Fund Manager for Overseas Investments
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. The performance details provided above are of Growth Option under Regular
Plan Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Rahul Pal manages 11 schemes of Mahindra Manulife Mutual Fund. The performance data for the schemes
which have not completed one year has not been provided.
Note: $The Benchmark of Mahindra Manulife Liquid Fund has been changed from CRISIL Liquid Debt B-I Index to CRISIL Liquid Debt A-I Index with effect from March 11, 2024. $The Benchmark of Mahindra Manulife
Ultra Short Duration Fund has been changed from CRISIL Ultra Short Duration Debt B-I Index to CRISIL Ultra Short Duration Debt A-I Index with effect from March 11, 2024. $The Benchmark of Mahindra Manulife
Short Duration Fund has been changed from CRISIL Short Duration Debt B-II Index to CRISIL Short Duration Debt A-II Index with effect from March 11, 2024. $The Benchmark of Mahindra Manulife Dynamic Bond Fund
has been changed from CRISIL Dynamic Bond B-III Index to CRISIL Dynamic Bond A-III Index with effect from March 11, 2024
This product is suitable for investors who are seeking*:
• Regular Income over short
term.
• Investment in debt and money market instruments.
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.